Patent · US Expired

Use of amphiphilic nucleoside phosphonoformic acid derivatives for the treatment of viral infectious diseases

US7279465B2 · kind B2 · utility

0Cited by

2References

6Claims

0Family size

Assignee

Eberhard Karls Universitat · DE

Inventors

Klaus Hamprecht · Lörrach, DE
Gerhard Jahn · Neunkirchen, DE
Herbert Schott

Key dates

Filing date	Dec 16, 2004
Grant date	Oct 9, 2007
Priority date	—
Expiry date	May 20, 2025

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a method for treating infectious diseases which are elicited by viruses which are pathogenic to humans comprising the step of administering an amphiphilic nucleoside-phosphonoformic acid derivative having an esterified or unesterified carboxyl group, preferably of a nucleoside-glycerol-(hydroxycarbonyl)-phosphonate, as an active compound.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.